Go Pro
OTCMKTS:BOPCF

BioPharma Credit (BOPCF) Stock Price, News & Analysis

BioPharma Credit logo
$0.93 0.00 (0.00%)
As of 09/8/2026

About BioPharma Credit Stock (OTCMKTS:BOPCF)

Advanced

Key Stats

Today's Range
$0.93
$0.93
50-Day Range
$0.93
$0.99
52-Week Range
$0.85
$1.02
Volume
78,135 shs
Average Volume
337,758 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BioPharma Credit (OTCMKTS: BOPCF) is a closed-end investment company that specializes in providing debt financing solutions to the global life sciences sector. The firm offers a range of credit products—including senior secured loans, convertible loans and royalty monetization structures—designed to meet the capital needs of biotechnology and pharmaceutical companies across pre-clinical, clinical and commercial stages. By focusing on secured and structured credit, BioPharma Credit seeks to deliver consistent income while managing risk through collateralized arrangements and diversified portfolios.

Since its inception in 2016, the company has built a track record of partnering with innovative drug developers and medical technology firms. BioPharma Credit’s financing model often fills gaps left by traditional equity markets and bank lenders, enabling emerging and mid-market life sciences businesses to advance critical research and development programs. The trust pursues a rigorous due-diligence process, assessing clinical outlook, intellectual property strength and market potential before structuring bespoke credit facilities that align with each borrower’s funding requirements.

Geographically, BioPharma Credit concentrates its investments in North America and select European markets, reflecting the region’s concentration of biotech clusters and research hubs. Its portfolio spans a variety of therapeutic areas, including oncology, rare diseases and immunology. The company’s management team draws on deep sector expertise in biopharma finance, aiming to balance yield generation with downside protection through collateral-backed lending and active portfolio monitoring.

AI Generated. May Contain Errors.

Receive BOPCF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioPharma Credit and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BOPCF Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

BOPCF Stock Analysis - Frequently Asked Questions

BioPharma Credit's stock was trading at $0.8503 at the beginning of the year. Since then, BOPCF stock has increased by 8.9% and is now trading at $0.9262.

Shares of BOPCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
OTCMKTS:BOPCF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (OTCMKTS:BOPCF) was last updated on 9/9/2026 by MarketBeat.com Staff.
From Our Partners